Gain insight into the innovative ways pharma collects and analyses evidence to demonstrate product value. Evidence 2016 Congress Americas brings you experts to discuss practical solutions to your data challenges. The size and scope of the data used is ever expanding, especially in the real world setting. Hear from payers, pharma, patient led organisations and providers as we discuss fresh ways to satisfy their expectations.

Payers are the ones who secure access to customers and this year, we have an unprecedented number of international payers at our congress. Meeting evidence requirements for drugs is critical, this is a not-to-be-missed opportunity to hear from a diverse selection of organisations at an evidence focused forum. The meeting is co-located with Market Access World USA and will focus on the opportunities to maximise value in evidence based research and market access strategy. The two day congress will examine the current healthcare environment, strategies and future opportunities.

Join us to learn how to assess and demonstrate tangible value in evidence based research and collaborate with all stakeholders for the benefit of the patient.

Who should attend?

Heads of:

  • HTA 
  • Market Access 
  • Health Economics 
  • Outcomes Research 
  • Health Policy 
  • Epidemiology 
  • Reimbursement 
  • Pricing 
  • Pharmacoeconomics 
  • Clinical trials 
  • Clinical research 
  • Post marketing Surveillance 
  • Medical Affairs 
  • Pharmacoepidemiology 
  • Investigator sponsored studies 
  • Clinical Data Management 

 Why attend?

  • Explore how to meet payers’ expectations
  • Discover the power of big data
  • Assess strategies to optimise PROs and prioritise value
  • Review the healthcare environment and examine who will be the future decision makers
  • Develop the right type and size of data to demonstrate evidence
  • Discover new approaches in RWE: how to meet the new realities of healthcare
  • Network with industry peers, pioneers and innovators and take new ideas and contacts back to the office
  • Discuss the impacts of effective evidence for more efficient clinical trials
  • Gain practical guidance and turnaround strategies – only the latest, most exciting and innovative stories shared
  • How to achieve success in evidence for the future – hear from the best and brightest minds in and outside industry